Ipamorelin + Tesamorelin Blend dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (1200 mcg @ 75 kg). Educational only — never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 748–1012 mcg | 0.75–1.01 mL | 30–41 units0.30–0.40 mL | — |
| 60–75 kg / 132–165 lb | 918–1242 mcg | 0.92–1.24 mL | 37–50 units0.37–0.50 mL | — |
| 75–90 kg / 165–198 lb | 1122–1518 mcg | 1.12–1.52 mL | 45–61 units0.45–0.61 mL | — |
| 90–105 kg / 198–231 lb | 1326–1794 mcg | 1.33–1.79 mL | 53–72 units0.53–0.72 mL | — |
| >105 kg / >231 lb | 1530–2070 mcg | 1.53–2.07 mL | 61–83 units0.61–0.83 mL | — |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. No published half-life on file for Ipamorelin + Tesamorelin Blend; the elapsed-time column is hidden.
Ipamorelin + Tesamorelin Blend by goal
Read Ipamorelin + Tesamorelin Blend's profile and dosing through a specific research-goal lens.
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.